LH
Laboratory Corporation of America Holdings
NYSE: LH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$360.25
+8.78% today
Updated 2026-10-28
Market cap
$26.36B
P/E ratio
26.89
P/S ratio
1.84x
EPS (TTM)
$12.09
Dividend yield
0.91%
52W range
$242 – $341
Volume
0.7M
Laboratory Corporation of America Holdings (LH) Insider transactions
Net insider activity
Net buying (27,578 shares)
Buy transactions
37
Sell transactions
63
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-01 | VAUGHN, BRYAN T | EVP and President, Diagnostics | Buy | 1,500 | — | — |
| 2026-09-01 | OYEGUNWA, AKINBOLADE | EVP, CIO & CTO | Buy | 750 | — | — |
| 2026-09-01 | MELTZER, JONATHAN C | EVP, COO | Buy | 900 | — | — |
| 2026-09-01 | CAVENEY, BRIAN J | EVP, Pres of BLS, CMO & CSO | Buy | 3,000 | — | — |
| 2026-08-17 | ANDERSON, KERRII B | Director | Sale | 3,000 | $318.02 | $954060.00 |
| 2026-08-11 | SCHECHTER, ADAM H | Director, President & CEO | Sale | 4,669 | $320.37 | $1.50M |
| 2026-08-04 | SUMMY, AMY B. | EVP, Chief Marketing Officer | Sale | 924 | $306.74 | $283427.76 |
| 2026-08-03 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Sale | 1,338 | — | — |
| 2026-08-03 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Sale | 1,338 | $309.23 | $413751.21 |
| 2026-08-03 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Sale | 82 | $309.22 | $25356.04 |
| 2026-07-02 | VAUGHN, BRYAN T | EVP and President, Diagnostics | Sale | 234 | $286.19 | $66968.46 |
| 2026-07-02 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Sale | 92 | $286.19 | $26329.48 |
| 2026-07-01 | VAUGHN, BRYAN T | EVP and President, Diagnostics | Sale | 327 | — | — |
| 2026-07-01 | VAUGHN, BRYAN T | EVP and President, Diagnostics | Buy | 327 | — | — |
| 2026-07-01 | VAUGHN, BRYAN T | EVP and President, Diagnostics | Sale | 93 | $283.88 | $26400.84 |
| 2026-07-01 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Sale | 256 | — | — |
| 2026-07-01 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Buy | 256 | — | — |
| 2026-07-01 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Sale | 73 | $283.88 | $20723.24 |
| 2026-06-08 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Sale | 762 | $263.89 | $201084.18 |
| 2026-05-11 | SCHECHTER, ADAM H | Director, President & CEO | Sale | 5,903 | $254.50 | $1.50M |
| 2026-03-27 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Sale | 1,633 | $267.05 | $436092.65 |
| 2026-03-27 | MELTZER, JONATHAN C | EVP, Operations | Sale | 839 | $267.05 | $224054.95 |
| 2026-03-26 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Buy | 2,388 | — | — |
| 2026-03-26 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Sale | 755 | $268.38 | $202626.90 |
| 2026-03-26 | VAUGHN, BRYAN T | EVP, Diagnostics | Buy | 1,584 | — | — |
| 2026-03-26 | VAUGHN, BRYAN T | EVP, Diagnostics | Sale | 451 | $268.38 | $121039.38 |
| 2026-03-26 | VAN, DER VAART SANDRA D | EVP, Corporate Affairs | Buy | 6,382 | — | — |
| 2026-03-26 | VAN, DER VAART SANDRA D | EVP, Corporate Affairs | Sale | 2,722 | $268.38 | $730530.36 |
| 2026-03-26 | SUMMY, AMY B. | EVP, Chief Marketing Officer | Buy | 3,994 | — | — |
| 2026-03-26 | SUMMY, AMY B. | EVP, Chief Marketing Officer | Sale | 1,836 | $268.38 | $492745.68 |
| 2026-03-26 | SCHROEDER, MARK S | EVP, Pres Diagnostics & COO | Buy | 9,304 | — | — |
| 2026-03-26 | SCHROEDER, MARK S | EVP, Pres Diagnostics & COO | Sale | 4,600 | $268.38 | $1.23M |
| 2026-03-26 | SCHROEDER, MARK S | EVP, Pres Diagnostics & COO | Buy | 2,968 | — | — |
| 2026-03-26 | SCHROEDER, MARK S | EVP, Pres Diagnostics & COO | Sale | 1,468 | $268.38 | $393981.84 |
| 2026-03-26 | SCHECHTER, ADAM H | Director, President & CEO | Buy | 58,470 | — | — |
| 2026-03-26 | SCHECHTER, ADAM H | Director, President & CEO | Sale | 26,106 | $268.38 | $7.01M |
| 2026-03-26 | OYEGUNWA, AKINBOLADE | EVP, CIO & CTO | Buy | 1,340 | — | — |
| 2026-03-26 | OYEGUNWA, AKINBOLADE | EVP, CIO & CTO | Sale | 382 | $268.38 | $102521.16 |
| 2026-03-26 | MELTZER, JONATHAN C | EVP, Operations | Buy | 2,388 | — | — |
| 2026-03-26 | MELTZER, JONATHAN C | EVP, Operations | Sale | 711 | $268.38 | $190818.18 |
| 2026-03-26 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Buy | 1,584 | — | — |
| 2026-03-26 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Sale | 451 | $268.38 | $121039.38 |
| 2026-03-26 | GRAHAM, ANITA Z | EVP, CHRO | Buy | 6,604 | — | — |
| 2026-03-26 | GRAHAM, ANITA Z | EVP, CHRO | Sale | 2,879 | $268.38 | $772666.02 |
| 2026-03-26 | CAVENEY, BRIAN J | EVP, Pres of ED, CMO & CSO | Buy | 9,304 | — | — |
| 2026-03-26 | CAVENEY, BRIAN J | EVP, Pres of ED, CMO & CSO | Sale | 4,042 | $268.38 | $1.08M |
| 2026-03-26 | CAVENEY, BRIAN J | EVP, Pres of ED, CMO & CSO | Buy | 1,986 | — | — |
| 2026-03-26 | CAVENEY, BRIAN J | EVP, Pres of ED, CMO & CSO | Sale | 863 | $268.38 | $231611.94 |
| 2026-03-26 | BAILEY, MEGAN D. | EVP, Pres, Central Labs & Intl | Buy | 1,184 | — | — |
| 2026-03-26 | BAILEY, MEGAN D. | EVP, Pres, Central Labs & Intl | Sale | 481 | $268.38 | $129090.78 |
| 2026-03-03 | SCHECHTER, ADAM H | Director, President & CEO | Sale | 8,705 | $279.96 | $2.44M |
| 2026-02-27 | VAN, DER VAART SANDRA D | EVP, Corporate Affairs | Sale | 548 | $284.91 | $156130.68 |
| 2026-02-24 | CAVENEY, BRIAN J | EVP, Pres of ED, CMO & CSO | Sale | 1,500 | $286.31 | $429457.50 |
| 2026-02-19 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Sale | 666 | $277.94 | $185108.04 |
| 2026-02-12 | MELTZER, JONATHAN C | EVP, Operations | Sale | 87 | $290.42 | $25266.54 |
| 2026-02-11 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Sale | 536 | — | — |
| 2026-02-11 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Sale | 160 | — | — |
| 2026-02-11 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Buy | 536 | — | — |
| 2026-02-11 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Buy | 160 | — | — |
| 2026-02-11 | WILKINSON, PETER J | SVP, Chief Accounting Officer | Sale | 46 | $289.89 | $13334.94 |
| 2026-02-11 | WENGEL, KATHRYN E | Director | Sale | 897 | — | — |
| 2026-02-11 | WENGEL, KATHRYN E | Director | Buy | 897 | — | — |
| 2026-02-11 | WANG, JULIA AIJUN | Chief Financial Officer, EVP | Sale | 860 | — | — |
| 2026-02-11 | WANG, JULIA AIJUN | Chief Financial Officer, EVP | Buy | 860 | — | — |
| 2026-02-11 | WANG, JULIA AIJUN | Chief Financial Officer, EVP | Sale | 245 | $289.89 | $71023.05 |
| 2026-02-11 | VAUGHN, BRYAN T | EVP, Diagnostics | Sale | 323 | — | — |
| 2026-02-11 | VAUGHN, BRYAN T | EVP, Diagnostics | Buy | 323 | — | — |
| 2026-02-11 | VAUGHN, BRYAN T | EVP, Diagnostics | Sale | 93 | $289.89 | $26959.77 |
| 2026-02-11 | VAN, DER VAART SANDRA D | EVP, Corporate Affairs | Sale | 376 | — | — |
| 2026-02-11 | VAN, DER VAART SANDRA D | EVP, Corporate Affairs | Buy | 376 | — | — |
| 2026-02-11 | VAN, DER VAART SANDRA D | EVP, Corporate Affairs | Sale | 99 | $289.89 | $28699.11 |
| 2026-02-11 | SUMMY, AMY B. | EVP, Chief Marketing Officer | Sale | 230 | — | — |
| 2026-02-11 | SUMMY, AMY B. | EVP, Chief Marketing Officer | Buy | 230 | — | — |
| 2026-02-11 | SUMMY, AMY B. | EVP, Chief Marketing Officer | Sale | 83 | $289.89 | $24060.87 |
| 2026-02-11 | SCHROEDER, MARK S | EVP, Pres Diagnostics & COO | Sale | 806 | — | — |
| 2026-02-11 | SCHROEDER, MARK S | EVP, Pres Diagnostics & COO | Buy | 806 | — | — |
| 2026-02-11 | SCHROEDER, MARK S | EVP, Pres Diagnostics & COO | Sale | 259 | $289.89 | $75081.51 |
| 2026-02-11 | SCHECHTER, ADAM H | Director, President & CEO | Sale | 3,656 | — | — |
| 2026-02-11 | SCHECHTER, ADAM H | Director, President & CEO | Sale | 5,273 | $284.38 | $1.50M |
| 2026-02-11 | SCHECHTER, ADAM H | Director, President & CEO | Buy | 3,656 | — | — |
| 2026-02-11 | SCHECHTER, ADAM H | Director, President & CEO | Sale | 1,521 | $289.89 | $440922.69 |
| 2026-02-11 | ROTHMAN, PAUL | Director | Sale | 897 | — | — |
| 2026-02-11 | ROTHMAN, PAUL | Director | Buy | 897 | — | — |
| 2026-02-11 | PARHAM, RICHELLE P | Director | Sale | 897 | — | — |
| 2026-02-11 | PARHAM, RICHELLE P | Director | Buy | 897 | — | — |
| 2026-02-11 | OYEGUNWA, AKINBOLADE | EVP, CIO & CTO | Sale | 230 | — | — |
| 2026-02-11 | OYEGUNWA, AKINBOLADE | EVP, CIO & CTO | Buy | 230 | — | — |
| 2026-02-11 | OYEGUNWA, AKINBOLADE | EVP, CIO & CTO | Sale | 68 | $289.89 | $19712.52 |
| 2026-02-11 | NEUPERT, PETER M | Director | Sale | 897 | — | — |
| 2026-02-11 | NEUPERT, PETER M | Director | Buy | 897 | — | — |
| 2026-02-11 | MELTZER, JONATHAN C | EVP, Operations | Sale | 243 | — | — |
| 2026-02-11 | MELTZER, JONATHAN C | EVP, Operations | Buy | 243 | — | — |
| 2026-02-11 | MELTZER, JONATHAN C | EVP, Operations | Sale | 70 | $289.89 | $20292.30 |
| 2026-02-11 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Sale | 216 | — | — |
| 2026-02-11 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Buy | 216 | — | — |
| 2026-02-11 | KYLE, KATHRYN W | EVP, Chief Legal Officer | Sale | 62 | $289.89 | $17973.18 |
| 2026-02-11 | KONG, GARHENG | Director | Sale | 897 | — | — |
| 2026-02-11 | KONG, GARHENG | Director | Buy | 897 | — | — |
| 2026-02-11 | KLIPHOUSE, KIRSTEN MARIE | Director | Sale | 897 | — | — |
| 2026-02-11 | KLIPHOUSE, KIRSTEN MARIE | Director | Buy | 897 | — | — |
Frequently asked questions
Are LH insiders buying or selling?
Over the transactions on record, LH insiders have been net sellers, with about $23.96M in stock sold across 63 sales. The entries tagged as buys are stock grants and option exercises recorded at $0, not open-market purchases.
Does insider selling at LH mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which LH insiders are selling the most?
Recent selling is concentrated in a few names. SCHECHTER, ADAM H accounts for the largest share on record, with about $14.38M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.